Castle Biosciences Inc.

NASDAQ: CSTL · Real-Time Price · USD
20.55
0.46 (2.29%)
At close: Aug 18, 2025, 3:59 PM
20.56
0.05%
After-hours: Aug 18, 2025, 05:31 PM EDT

Castle Biosciences Revenue

Castle Biosciences reported an annual revenue of $332.07M, reflecting a 51.09% growth. For the quarter ending June 30, 2025, Castle Biosciences generated $86.19M in revenue.
Revenue (ttm)
332.07M
Revenue Growth
51.09%
Price / Sales Ratio
2.23
Revenue / Employee
423.56K
Employees
784
Market Cap
596.12M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 332.07M +51.09%
Dec 31, 2023 219.79M +60.38%
Dec 31, 2022 137.04M +45.65%
Dec 31, 2021 94.08M +50.18%
Dec 31, 2020 62.65M +20.79%
Dec 31, 2019 51.87M +127.62%
Dec 31, 2018 22.79M +65.67%
Dec 31, 2017 13.75M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.